21 CFR Part 11 is a regulation established by the United States Food and Drug Administration (FDA). It defines the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. It is commonly used by FDA-regulated industries, such as pharmaceutical, biotechnology, medical device, and food companies, to ensure the integrity and reliability of electronic data used in research, development, manufacturing, and quality control processes. Compliance with 21 CFR Part 11 is essential for these companies to gain FDA approval for their products and avoid regulatory issues.
This tech insight summary was produced by Sumble. We provide rich account intelligence data.
On our web app, we make a lot of our data available for browsing at no cost.
We have two paid products, Sumble Signals and Sumble Enrich, that integrate with your internal sales systems.